A drug that targets the deadliest form of breast cancer has recently been found to elicit no side effects, and triggered an immune response in 75% of patients. Conducted at the Cleveland Clinic with funding from the Pentagon, the vaccine was administered to 16 women in three separate doses. The form of the vaccine that […]
The post Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients appeared first on Good News Network.